-
1دورية أكاديمية
المؤلفون: Slezak AJ; Pritzker School of Molecular Engineering, University of Chicago, Chicago, IL., Chang K; Pritzker School of Molecular Engineering, University of Chicago, Chicago, IL., Beckman TN; Committee on Molecular Metabolism and Nutrition, University of Chicago, Chicago, IL., Refvik KC; Pritzker School of Molecular Engineering, University of Chicago, Chicago, IL., Alpar AT; Pritzker School of Molecular Engineering, University of Chicago, Chicago, IL., Lauterbach AL; Pritzker School of Molecular Engineering, University of Chicago, Chicago, IL., Solanki A; Animal Resource Center, University of Chicago, Chicago, IL., Kwon JW; Department of Pathology, University of Chicago, Chicago, IL., Gomes S; Pritzker School of Molecular Engineering, University of Chicago, Chicago, IL., Mansurov A; Pritzker School of Molecular Engineering, University of Chicago, Chicago, IL., Hubbell JA; Pritzker School of Molecular Engineering, University of Chicago, Chicago, IL.; Committee on Immunology, University of Chicago, Chicago, IL.; Committee on Cancer Biology, University of Chicago, Chicago, IL.
المصدر: Blood advances [Blood Adv] 2024 Apr 09; Vol. 8 (7), pp. 1747-1759.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
مواضيع طبية MeSH: Cysteine*/therapeutic use , Leukemia, Myeloid, Acute*/drug therapy, Humans ; Mice ; Animals ; Disease Models, Animal ; Adjuvants, Immunologic ; Antigens, Neoplasm ; Lymphocyte Activation ; Disulfides/therapeutic use